These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 843950)

  • 1. Studies on the relationship of binding affinity to psychoactive and anticholingergic potency of a group of psychotomimetic glycolates.
    Baumgold J; Abood LG; Aronstam R
    Brain Res; 1977 Mar; 124(2):331-40. PubMed ID: 843950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects and binding affinities of two stereoisomeric psychotomimetic glycolates.
    Lowy K; Abood LG; Raines H
    J Neurosci Res; 1976; 2(2):157-65. PubMed ID: 950679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of an anticholinergic psychotomimetic agent on behaviour in cats controlled by an auditory stimulus.
    Lowy K; Weiss B; Abood LG
    Neuropharmacology; 1974 Aug; 13(8):707-18. PubMed ID: 4444757
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral effects of anticholinergic psychotomimetics.
    Fusek J; Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(3):191-3. PubMed ID: 5113836
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscarinic cholinergic binding in rat brain.
    Yamamura HI; Snyder SH
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1725-9. PubMed ID: 4151898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical factors influencing the psychotomimetic potency of glycolate esters.
    Baumgold J; Abood LG; Hoss WP
    Life Sci; 1975 Aug; 17(4):603-11. PubMed ID: 1186427
    [No Abstract]   [Full Text] [Related]  

  • 7. Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
    Atkinson ER; McRitchie DD; Shoer LF; Harris LS; Archer S; Aceto MD; Pearl J; Luduena FP
    J Med Chem; 1977 Dec; 20(12):1612-7. PubMed ID: 592326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers.
    Wang LY; Wang Y; Zheng JQ; Zhong BH; Liu H; Dong SJ; Ruan JX; Liu KL
    Acta Pharmacol Sin; 2005 May; 26(5):527-32. PubMed ID: 15842768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral effects of anticholinergic compounds.
    Albanus L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(4):305-26. PubMed ID: 5536020
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study on pharmacological effects of DM-phencynonate hydrochloride and its optical isomers.
    Wang LY; Zheng JQ; Wang Y; Zhong BH; Ruan JX; Liu LL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1187-92. PubMed ID: 16174434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism by cholinergic drugs of behavioural effects in cats of an anticholinergic psychotomimetic drug and enhancement by nicotine.
    Lowy K; Abood ME; Drexler M; Abood LG
    Neuropharmacology; 1977 Jun; 16(6):399-403. PubMed ID: 904770
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of a new cholinolytic--8018--and its optical isomers on the central muscarinic and nicotinic receptors.
    Niu WZ; Zhao DL; Liu CG
    Arch Int Pharmacodyn Ther; 1990; 304():64-74. PubMed ID: 2241419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
    Niedzwiecki DM; Cubeddu LX; Mailman RB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):126-33. PubMed ID: 2746492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anticholinergic potency to psychotomimetic action of glycolate esters.
    Lipman VC
    Proc Soc Exp Biol Med; 1967 Oct; 126(1):173-6. PubMed ID: 6066160
    [No Abstract]   [Full Text] [Related]  

  • 15. New classes of antimuscarinic agents endowed with selective antispasmodic properties. 1-Arylsulfonyl pyrrolidin-2-ones and 2-thiones, 1-arylsulfonyl piperidin-2-ones and 2-thiones and 1-arylsulfonyl hexahydro-2H-azepin-2-one.
    Toja E; Parini C; Bonetti C; Hunt P; Fortin M; Barzaghi F; Cesana R; Maggioni A; Nencioni A; Galliani G
    Arzneimittelforschung; 1994 Apr; 44(4):501-9. PubMed ID: 8011004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
    Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of glycolate esters on conditioned behavior].
    Mei ZT
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):1-3. PubMed ID: 3158150
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of anticholinergic hallucinogens on spontaneous and conditioned behaviour in rats.
    Kabes J; Fink Z
    Act Nerv Super (Praha); 1971; 13(3):195-6. PubMed ID: 5113839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.